COA

Pangaea Logistics Solutions Ltd. Reports Financial Results for the Quarter Ended March 31, 2024

Retrieved on: 
Giovedì, Maggio 9, 2024
Port of Palm Beach, COA, Handymax, TCE, Partnership, Transport, Acquisition, Eastern Time Zone, Adjustment, Lunar phase, Growth, Airline

NEWPORT, R.I., May 9, 2024 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (Nasdaq: PANL), a global provider of comprehensive maritime logistics solutions, announced today its results for the three months ended March 31, 2024.

Key Points: 
  • NEWPORT, R.I., May 9, 2024 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (Nasdaq: PANL), a global provider of comprehensive maritime logistics solutions, announced today its results for the three months ended March 31, 2024.
  • As of March 31, 2024, the Company had $95.9 million in cash and cash equivalents.
  • "In 2024, our capital deployment priorities are on the build-out of our on-shore logistics business, together continued investment in our fleet.
  • The Company's management team will host a conference call to discuss the Company's financial results on Friday, May 10, 2024 at 8:00 a.m., Eastern Time (ET).

Parsons Receives Innovation Transportation Solutions Award from WTS Colorado

Retrieved on: 
Mercoledì, Maggio 8, 2024
Lynx, COA, Water quality, Public, City, Denver Union Station, Safety, Federal Transit Administration, Woman, WTS, NEPA, CDOT, Partnership, PSN, Water, BRT, Colorado Department of Transportation, FTA, Engineering, RTD, County, DRCOG, Anschutz Medical Campus, Regional Transportation District, Parsons Corporation

CHANTILLY, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN) announced today that the company’s East Colfax Avenue Bus Rapid Transit (BRT) project received the 2024 Innovation Transportation Solutions Award from the Women in Transportation (WTS) Colorado Chapter.

Key Points: 
  • CHANTILLY, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN) announced today that the company’s East Colfax Avenue Bus Rapid Transit (BRT) project received the 2024 Innovation Transportation Solutions Award from the Women in Transportation (WTS) Colorado Chapter.
  • WTS is an international organization dedicated to shaping the future of transportation for the public good through the global advancement of women.
  • Parsons is a Champion Partner and active participant in WTS and currently serves as prime for final design of the East Colfax BRT, in addition to providing preliminary engineering and NEPA review.
  • Through a series of design charettes concurrent with direct outreach to the community, the Parsons team created the design which would become The Lynx.

Children of America® Spotlights Heroic Teacher & Top Performers

Retrieved on: 
Mercoledì, Aprile 24, 2024
COA, Recognition, Safety, School, Child, Lead, Founder's Award, Student

MOUNT LAUREL, N.J., April 24, 2024 /PRNewswire-PRWeb/ -- Children of America® (COA), held a red-carpet Awards Gala at the 2024 Leadership Summit April 6th in New Jersey. The transformative event gathered company leaders to honor one of their own heroic teachers and recognize the exceptional individuals shaping the future of the childcare industry.

Key Points: 
  • The transformative event gathered company leaders to honor one of their own heroic teachers and recognize the exceptional individuals shaping the future of the childcare industry.
  • During a routine day at COA Marlton, NJ, DeAngeline Sebastian demonstrated extraordinary composure and expertise when a student experienced a sudden seizure.
  • Her quick response and unwavering dedication undoubtedly played a pivotal role in preventing a potentially tragic outcome.
  • "We are immensely proud to honor Ms. Sebastian for her remarkable bravery and selflessness," said COA CEO, Ted Hockenberry.

Organic Payment Gateways Announces a "Square Payment Processing Alternatives for CBD" Support Program

Retrieved on: 
Lunedì, Aprile 15, 2024
Online, BigCommerce, Social media, Risk, COA, Shopify, PayPal, WooCommerce, Wix, Marketing, Online shopping

CBD site owners who utilize Organic Payment Gateways' "Square Payment Processing Alternatives for CBD" placement program will need to answer some basic questions, such as exactly what products they will be selling, how long they were processing credit cards, and their refund and quality assurance policies.

Key Points: 
  • CBD site owners who utilize Organic Payment Gateways' "Square Payment Processing Alternatives for CBD" placement program will need to answer some basic questions, such as exactly what products they will be selling, how long they were processing credit cards, and their refund and quality assurance policies.
  • Organic Payment Gateways will gather all preliminary information and then act as a consultant, assisting with the application process and website integration.
  • According to Organic Payment Gateways, the processors compensate them in exchange for screening and introducing qualified CBD site owners.
  • To learn more about Organic Payment Gateways' "Square Payment Processing Alternatives for CBD" program, visit their site at https://organicpaymentgateways.com/cbd-payment-gateways/ and click the Start arrow at the bottom of the page.

Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute

Retrieved on: 
Martedì, Aprile 9, 2024
Psilocybin, First Nations, Wharerātā, Certificate, Patient, Ethics, FRA, COA, Synthetic, Health Canada, Trial of the century, GMP, Clinical trial, Ground substance, Safety, MDMA, Medsafe, Medicine, Pharmaceutical industry

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the signing of an international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute (Mātai), on behalf of the Tū Wairua Project.

Key Points: 
  • VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is proud to announce the signing of an international natural psilocybin supply agreement with New Zealand-Based Mātai Medical Research Institute (Mātai), on behalf of the Tū Wairua Project.
  • This agreement marks Optimi's first supply deal to New Zealand, a significant milestone for the company's global expansion efforts.
  • Under the terms of the agreement, Optimi will provide Mātai with a quantity of its validated GMP Full Spectrum Natural Psilocybin extract.
  • Further, the agreement includes tracked stability of the extract, ensuring the highest standards of GMP quality and compliance.

Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract

Retrieved on: 
Martedì, Aprile 2, 2024
Psilocybin, Psilocybe, Organization, Documentation, Learning, Certificate, Patient, Research, Good manufacturing practice, FRA, COA, International Council, Health Canada, GMP, Data collection, Quality, Harmonization, Ground substance, GACP, Water, Safety, ICH, MDMA, Good

Additionally, the Company has successfully completed the in-house encapsulation of psilocybin drug candidates in 5mg and 10mg dosage formats.

Key Points: 
  • Additionally, the Company has successfully completed the in-house encapsulation of psilocybin drug candidates in 5mg and 10mg dosage formats.
  • The third-party COA confirms critical information regarding potency, water content, microbial content, and heavy metal content, ensuring that the Natural Psilocybin Extract meets the predetermined specifications.
  • The completion of both extract validation and finished product testing aligns with Optimi's goal of advancing the drug candidate, marking significant progress toward its eventual release for human consumption.
  • “Obtaining successful results on the validation batches of psilocybin extract speaks to Optimi’s dedication to developing a repeatable, quality focused manufacturing process.

RollerCoaster Tycoon Celebrates 25th Anniversary with New Online Store

Retrieved on: 
Giovedì, Marzo 28, 2024
RollerCoaster Tycoon Classic, RollerCoaster Tycoon, COA, MDF, Wood, Video game

With a grand opening today, fans can now find a variety of exclusive apparel, accessories, and collectibles in the official RollerCoaster Tycoon store at atari.com .

Key Points: 
  • With a grand opening today, fans can now find a variety of exclusive apparel, accessories, and collectibles in the official RollerCoaster Tycoon store at atari.com .
  • To mark the 25th Anniversary of RollerCoaster Tycoon, Atari is offering a special treat: limited edition shadowbox art pieces showcasing the game's original box cover, each piece personally signed by the creator, Chris Sawyer.
  • “We are excited to celebrate such an important milestone with Chris and all Rollercoaster Tycoon fans,” said Wade Rosen, Chairman and CEO of Atari.
  • “Rollercoaster Tycoon is a rare game that continues to inspire joy among players 25 years after it was first introduced.”
    Atari operates Rollercoaster Tycoon games under a license agreement with Chris Sawyer, including Rollercoaster Tycoon Classic, Tycoon 2, Tycoon Deluxe, Touch, and Adventures Deluxe.

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

Retrieved on: 
Giovedì, Marzo 28, 2024
Community, AON, CSSBB, Growth, Doctor of Pharmacy, Health, Partnership, Education, Patient, Knowledge, Cancer, COA, Hope, Matter, Personalized medicine, Community Oncology Alliance, MD, Privacy, Competition, MBA, Confidentiality, Pharmacy, Physician, Medicine, Pharmaceutical industry

FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC) announced its attendance and panel participation at the annual Community Oncology Alliance (COA) conference from April 4 to April 5 in Orlando, Florida, to further its mission of closing the cancer care gap and ensuring the viability of community oncology.

Key Points: 
  • FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC) announced its attendance and panel participation at the annual Community Oncology Alliance (COA) conference from April 4 to April 5 in Orlando, Florida, to further its mission of closing the cancer care gap and ensuring the viability of community oncology.
  • Since its inception, AON has provided administrative support and access to critical offerings such as the in-house pharmacy and laboratory services to independent oncology medical practices.
  • The conference brings together today’s healthcare and community oncology leaders for two days of education and networking.
  • We understand the future of healthcare is a collective effort, and the conference provides a platform to foster unity and the exchange of information.

Palantir to Deliver Electromagnetic Battle Management - Joint Decision Support (EMBM-J DS) Prototype to the Defense Information Systems Agency (DISA)

Retrieved on: 
Venerdì, Marzo 29, 2024
Public Policy, Government, Defense, Technology, Software, Homeland Security, Other Defense, DISA, Unified combatant command, Emerging technologies, OTA, Joint task force, SVP, PLTR, COA, USSTRATCOM, Service, EMS, Management

Palantir Technologies Inc. (NYSE: PLTR) today announced that it was selected by the Defense Information Systems Agency (DISA) to deliver an Electromagnetic Battle Management - Joint Decision Support (EMBM-J DS) Prototype.

Key Points: 
  • Palantir Technologies Inc. (NYSE: PLTR) today announced that it was selected by the Defense Information Systems Agency (DISA) to deliver an Electromagnetic Battle Management - Joint Decision Support (EMBM-J DS) Prototype.
  • This effort will provide the Department of Defense with a cutting-edge software capability to support Joint Electromagnetic Spectrum Operations (JEMSO).
  • The award of prototype Other Transaction Authority (OTA) Agreement is worth $9.8 million over twelve months.
  • This Impact Level 6, web-based EMBM-J DS prototype will also integrate with Service tools and processes for Electromagnetic Battle Management, maximizing interoperability and coordination across the joint force.

Noetik Appoints Dr. Shafique Virani as Chief Business Officer

Retrieved on: 
Mercoledì, Marzo 27, 2024
Research, Technology, Health Technology, Software, Biotechnology, Pharmaceutical, Health, Science, Oncology, Artificial Intelligence, Recursion, Neuromyelitis optica spectrum disorder, University, Drug discovery, Patient, Cancer, Medicine, Doctor of Philosophy, Bayer, Therapy, COA, Machine learning, CSO, Multimedia, Pharmaceutical industry

Noetik , an AI-native biotechnology company leveraging advanced machine learning and proprietary data to discover and develop precision cancer immunotherapies announces the appointment of Dr. Shafique Virani as Chief Business Officer.

Key Points: 
  • Noetik , an AI-native biotechnology company leveraging advanced machine learning and proprietary data to discover and develop precision cancer immunotherapies announces the appointment of Dr. Shafique Virani as Chief Business Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240327236059/en/
    "We are thrilled to welcome Shaf to our team as Chief Business Officer.
  • Prior to joining Noetik, Dr. Virani served as Recursion’s Chief Corporate Development Officer, as well as the interim Chief Medical Officer as part of his tenure.
  • As Chief Business Officer, Dr. Virani will accelerate Noetik’s mission through both business development and portfolio strategy by identifying and facilitating strategically impactful transactions.